Tools

Consumer advocates are especially pleased with one provision of the newly enacted U.S. healthcare reform bill—a provision that sets up… »   

A two-drug combination destroys precancerous colon polyps with no effect on normal tissue, opening a new potential avenue for… »   

“Review by the Advisory Committee represents a critical milestone for Qnexa and for VIVUS. We believe Qnexa, if approved, could… »   

Vivus Inc. said Friday a Food and Drug Administration review panel will discuss its obesity drug candidate Qnexa on July… »   

Cedars-Sinai investigators funded by the Muscular Dystrophy Association are registering two dozen ambulatory men with Becker muscular dystrophy for… »   

Like a skittish driver slamming the brakes, a special class of T cells may be limiting the effectiveness of therapeutic… »   

Use of controversial anemia drugs at high levels likely worsens heart problems and possibly chances for survival in kidney patients,… »   

An experimental vaccine against an abnormal protein found in some tumors has the potential to delay the onset of inflammatory… »   

A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association… »   

Drugmakers Pfizer and GlaxoSmithKline signed a landmark 10-year deal on Tuesday to supply 60 million doses a year of cut-price… »